SJIA is considered an overactivation of the innate immune response, leading to exacerbated production of inflammatory cytokines such as IL-1β, IL-18 and IL-6 [1,2]. The gene discussed is IL18; the disease is systemic-onset juvenile idiopathic arthritis.